Surgeons in the Heart Center at Boston Children's Hospital have partnered with Edwards Lifesciences to launch a clinical study of a new prosthetic heart valve for patients born with a congenital heart defect. Called the COMMENCE - Pulmonary Valve Trial, the study will include up to 10 pediatric heart centers from around the US; Boston Children's is the trial's lead site.
InSilico Medicine is acquiring the advances in artificial intelligence to its R&D in drug discovery.
An innovative heat stress vest uses a smartphone app to monitor outdoor workers' health in real time.
Case Western Reserve University, Carnegie Mellon University, the University of Pittsburgh and West Virginia University are forming the Tri-State University Energy Alliance, to accelerate innovations to address challenges and opportunities facing the energy sector.
LDN information site revamped. LDN is the biggest patient-initiated drug discovery program in history. LDN research to date encompasses 14 clinical trials and 19 case reports/series, including diseases such as Crohn's, Parkinson's, MS, fibromyalgia and HIV. The number of LDN users worldwide has now reached 300,000 and this has been achieved without any commercial sponsorship.
A machine with hands of steel has revolutionized the speed and efficiency of the once-tedious process of plant grafting. Led by vegetable expert Richard Hassell, a team of scientists at Clemson University's Coastal Research and Education Center has recently unveiled a robotic system that grafts disease-resistant roots to robust plant tops as quickly as you can say chop-chop.
Kansas State University and Texas Tech University beef cattle researchers are collaborating on a feedlot cattle production and health research study.
The American Board of Medical Specialties (ABMS) announced today the recognition of Addiction Medicine as a new subspecialty. The American Board of Preventive Medicine, a Member Board of ABMS, sponsored the application for the new field to be a multispecialty subspecialty -- meaning that physicians certified by any Member Board of the ABMS can become certified in addiction medicine. The ABMS subspecialty recognition of Addiction Medicine has been championed by the American Board of Addiction Medicine.
Openly accessible literature is called 'the fabric and the substance of Open Science' in a small grant proposal, submitted to the Open Science Prize contest and published in the Research Ideas and Outcomes (RIO) open access journal. To tackle the issue of it being dispersed across thousands of website, the authors build on the existing prototype Paperity to suggest a global universal catalog of all open access scientific publications incorporated with many functionalities and features.
A new company has been formed to maximize the commercial impact of Edinburgh's world-leading animal science research. The company -- Roslin Technologies Ltd -- has been launched to facilitate the commercialization of research from the University of Edinburgh's Roslin Institute and Royal (Dick) School of Veterinary Studies in partnership with Edinburgh-based private equity advisor JB Equiry.